In addition, our basic science and
translational research efforts — particularly in the areas of the gut
microbiome, immunology, and microbiology — are contributing to the scientific advancement in the development, prevention, and treatment of IBD, and to the promise of more effective treatment strategies for future patients.
JAX has particular strengths in
research focused on understanding aging, behavior and addiction, computational biology, cancer, development and disease, gene expression, genetics and genomics, immunology and hematology, metabolism,
microbiome, neuroscience, reproductive biology, statistical and population genetics, stem cells, systems biology, and
translational medicine.